DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 59 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q4 2019$19,952,000
+53.4%
251,000
-6.4%
0.64%
+20.2%
Q3 2019$13,008,000
+5.2%
268,100
+14.1%
0.53%
+19.4%
Q2 2019$12,361,000
+399.0%
235,000
+37.1%
0.44%
+335.3%
Q4 2016$2,477,000
-37.3%
171,4280.0%0.10%
-44.6%
Q3 2016$3,951,000
-86.3%
171,428
-90.1%
0.18%
-83.7%
Q2 2016$28,764,000
+51.9%
1,733,828
+45.2%
1.13%
+40.2%
Q1 2016$18,934,000
-49.7%
1,193,811
+2.6%
0.81%
-47.1%
Q4 2015$37,626,000
+0.2%
1,163,811
+30.7%
1.52%
+5.0%
Q3 2015$37,549,000890,6201.45%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2015
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders